DMC Biotechnologies is at the forefront of sustainable chemical production through its innovative Dynamic Metabolic Control™ technology, which utilizes precision fermentation to create bio-based chemicals. This proprietary platform enhances the standardization, robustness, and predictability of fermentation processes, addressing long-standing challenges in the biotech industry. By leveraging agricultural feedstocks, DMC's technology not only produces chemicals in a cost-effective manner but also significantly reduces carbon emissions, exemplified by their L-alanine product, which boasts a 90% reduction in CO2 compared to traditional methods. This approach not only supports environmental sustainability but also strengthens supply chain resilience by enabling local production.

The company’s product portfolio spans various markets, including dietary supplements, nutraceuticals, cosmetic actives, and bio-based chemicals. DMC's commitment to innovation is evident in its ongoing development of new products and its collaboration with industry leaders to accelerate the commercialization of sustainable solutions. The recent establishment of a new research and development facility in North Carolina further underscores DMC's dedication to advancing metabolic engineering and fermentation technologies, positioning the company to meet the growing demand for sustainable chemical solutions in an evolving market landscape.

United States

DMC Biotechnologies has developed its Dynamic Metabolic Control technology, a novel, low cost technology for rapid engineering of robust microbial hosts that enables the production of a broad diversity of specialty chemicals, flavors, fragrances, neutracueticals, natural products, pharmaceuticals, and APIs.

DMC Biotechnologies

Company Details